4//SEC Filing
PETERS WILLIAM J 4
Accession 0001415889-24-020626
CIK 0001297184other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:32 PM ET
Size
8.5 KB
Accession
0001415889-24-020626
Insider Transaction Report
Form 4
PETERS WILLIAM J
DirectorCFO, EVP & TREASURER
Transactions
- Exercise/Conversion
Common Stock
2024-07-31$20.23/sh+10,282$208,005→ 104,385 total - Sale
Common Stock
2024-07-31$44.23/sh−10,282$454,773→ 94,103 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-07-31−10,282→ 4,943 totalExercise: $20.23Exp: 2029-03-15→ Common Stock (10,282 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024.
- [F2]Shares subject to the option are fully vested and immediately exercisable.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001263136
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:32 PM ET
- Size
- 8.5 KB